DOCHealthpeak Properties

$18.81+7.3% 1Y

Is the price fair?

Watch

At the top of its own P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 to watch, 2 without data
Vs its own P/E rangedearer than 81% of its own historyderived

Expensive vs its own history: P/E 53.7 vs a 33.3 median over 37 quarters (+61% vs median).

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)behind 88% of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What DOC's price assumes

Healthpeak Properties trades at 53.7× earnings against 38.1× for the median REIT - Healthcare Facilities name, more expensive than its own group.

53.7

Trailing P/E · REIT - Healthcare Facilities median 38.1 · 1.41× the median: the market pays up for this one

Price / sales
4.87

Price / sales · as of 2026-Q2

Price / book
1.83

Price / book · as of 2026-Q2

EV / sales
7.72

EV / sales

Details›
Price / bookas of 2026-Q2
1.83
EV / EBITas of 2026-Q2
152
EV / salesas of 2026-Q2
7.72
Real Estate median P/E130 names
25.0
REIT - Healthcare Facilities median P/E11 names
38.1
Market capitalisation
$13.5B
What the market has paid for these earnings: 37 quarters of its own multiple × $0.35 of trailing earnings per share
MethodPer share
Its own P/E history, lower quartile$6.18
Its own P/E history, median$11.67
Its own P/E history, upper quartile$17.35
52-week range$15.25 – $22.83
Today$18.81

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.